📈 Live Market Tracking
Every NSE and BSE corporate filing, read and explained by AI within minutes — impact, key figures, short/long-term view and what to watch.
Live · AI analyzer runs every 5 min (07:00–23:55 IST)
0 analysed today
FollowTelegram
0
Today
152,139
All-time analysed
43,645
Positive
6,747
Negative
92,898
Neutral
8,781
Watch
📊 Last 7 days — analysed filings by sentiment
Note: These are AI-generated, educational summaries of public NSE
filings — grounded in each document, but not investment advice and possibly incomplete.
Verify against the original filing and consult a SEBI-registered adviser before acting.
224 announcements match the current filters (relevance ≥ 5).
Asian Hotels (North) to Raise ₹300 Crore via NCDs Amid ₹770 Crore Loan Default
Asian Hotels (North) Limited has approved the issuance of unlisted, secured Non-Convertible Debentures (NCDs) worth ₹300 crore on a private placement basis. The debentures carry a high interest rate of 12.5% per annum, reflecting the company's current financial risk profile. Crucially, the company disclosed an existing default of ₹770.12 crore on loans from banks and financial institutions as of December 31, 2025. The new debt is secured against the Hyatt Regency Delhi property and is slated for repayment over a 2-year tenure.
Key Highlights
Proposed issuance of 3,000 unlisted, secured NCDs totaling ₹300 crore via private placement.
High coupon rate of 12.5% p.a. payable monthly with a 2-year maturity period.
Company disclosed a significant default of ₹770.12 crore on existing bank/FI loans as of Dec 31, 2025.
NCDs are secured by a first pari-passu charge on the Hyatt Regency Delhi hotel property and movable assets.
Redemption schedule includes 10% at 12 months, 10% at 18 months, and the remaining 80% at the end of 2 years.
👀 What to Watch
Investors should remain extremely cautious as the ₹300 crore fundraise is significantly smaller than the disclosed ₹770 crore default. Monitor whether these funds are used for a formal debt restructuring or if the company's liquidity crisis continues to deepen.
NHPC Board Approves Rs 2,000 Crore Bond Issuance via Private Placement
NHPC Limited's Board of Directors has approved the issuance of AH-Series Bonds worth up to Rs 2,000 crore. These bonds are unsecured, redeemable, taxable, and non-convertible, intended to be issued in one or more tranches. This fundraising activity is part of the company's pre-approved borrowing plan for the financial year 2025-26. The issuance will be conducted through a private placement route, targeting institutional investors.
Key Highlights
Board approved issuance of AH-Series Bonds up to a total of Rs 2,000 crore
Bonds are unsecured, redeemable, taxable, and non-convertible in nature
Fundraising is part of the company's borrowing plan for FY 2025-26
Approval includes the General Information Document (GID) and Key Information Document (KID) for the issue
The issuance will be executed in one or more tranches through private placement
👀 What to Watch
Investors should monitor the coupon rates at which these bonds are placed to gauge the company's cost of debt. This is a routine capital-raising activity for a PSU to fund its ongoing projects and does not necessitate immediate portfolio changes.
Asian Hotels (North) Reports ₹770.12 Crore Default on Bank Loans
Asian Hotels (North) Limited has disclosed a significant default on its financial obligations as of December 31, 2025. The company reported that its entire outstanding loan amount of ₹770.12 crore from banks and financial institutions is currently in default. This total financial indebtedness reflects a severe liquidity crisis, as 100% of the bank-related debt is overdue. The disclosure was made in compliance with SEBI's mandatory reporting requirements for loan defaults.
Key Highlights
Total amount of default on bank loans and revolving facilities stands at ₹770.12 crore.
The entire outstanding bank debt of ₹770.12 crore is classified as being in default as of December 31, 2025.
Total financial indebtedness of the listed entity is reported at ₹770.12 crore.
No defaults were reported regarding unlisted debt securities such as NCDs or NCRPS.
👀 What to Watch
Investors should exercise extreme caution as the company's default on its entire bank debt indicates a high risk of insolvency. It is advisable to monitor for any updates regarding debt restructuring or potential legal actions by the lenders.
Apollo Sindoori Subsidiary Launches 'Smart Super Clean' Service; Pilot Starts in Chennai
Apollo Sindoori Hotels' wholly owned subsidiary, Sindoori Management Solutions, has entered the B2C deep cleaning market with the launch of 'Smart Super Clean.' The service officially commenced a three-month pilot phase in Chennai on January 7, 2026, utilizing three specialized service vans. Each unit features a five-member crew providing high-standard residential and commercial cleaning, including medical-grade sanitization. Following the pilot, the company plans to expand this service to other major metro cities across India.
Key Highlights
Launched 'Smart Super Clean' professional deep cleaning service via wholly owned subsidiary.
Pilot phase initiated in Chennai with 3 fully equipped service vans and 5-member crews.
Service model follows a B2C cash-and-carry approach targeting residential and commercial sectors.
Expansion to other Indian metro cities planned after a 3-month successful pilot period.
Service portfolio includes specialized medical cleaning, pest control, and eco-friendly solutions.
👀 What to Watch
Investors should monitor the successful completion of the three-month pilot and the subsequent rollout to other metros as a sign of scalable revenue diversification. The move into high-standard hygiene services leverages the company's existing hospitality expertise.
Apollo Sindoori Subsidiary Bags Three Contracts Worth Over Rs 64 Crore
Apollo Sindoori Hotels' subsidiary, Sindoori Management Solutions, has secured three significant facility management and manpower contracts totaling approximately Rs 64.31 crore. The largest contract is from Tata Main Hospital, valued at Rs 43.52 crore for a period of 33 months, involving integrated facility management for a 1000-bedded hospital. Additionally, the company won a Rs 15.57 crore contract from Overseas Manpower Corporation and a Rs 5.22 crore contract from the Government of Rajasthan. These wins demonstrate the company's growing footprint in the healthcare and government facility management sectors.
Key Highlights
Total contract value across three new orders is approximately Rs 64.31 crore (excluding GST).
Largest order from Tata Main Hospital worth Rs 43.52 crore for 33 months, involving 750 personnel.
Secured a 1-year contract worth Rs 15.57 crore from Overseas Manpower Corporation Ltd for Chennai zone.
Awarded a 2-year facility management contract worth Rs 5.22 crore from the Government of Rajasthan Secretariat.
👀 What to Watch
Investors should view this as a positive development for revenue visibility over the next 1-3 years. Monitor the execution of these contracts and their impact on operating margins in upcoming quarterly results.
Indian Hume Pipe Sells Hyderabad Land Asset for INR 173.96 Crores
Indian Hume Pipe Company Limited (IHP) has successfully completed the sale of its Hyderabad land asset for a total consideration of INR 173.96 Crores. The land, measuring approximately 15,310.80 square meters, was sold to ASBL Private Limited through a competitive bidding process. This transaction follows the company's recent acquisition of full ownership of the property, which it had held on leasehold for 94 years. The significant cash inflow is expected to strengthen the company's liquidity position and balance sheet.
Key Highlights
Sale of 18,311.57 Sq. Yds. (approx. 15,310.80 Sq. Mtrs.) land in Hyderabad for INR 173.96 Crores.
The buyer is ASBL Private Limited, formerly known as Ashoka Builders India Private Limited.
The property was held on leasehold for 94 years before ownership was recently obtained and the sale concluded.
The transaction was finalized through a competitive bidding process with JLL acting as transaction advisors.
Proceeds represent a major monetization of a non-core asset for the company.
👀 What to Watch
Investors should view this as a positive liquidity event; monitor the company's upcoming financial statements to see if the proceeds are used for debt reduction, expansion, or a special dividend.
Indian Hume Pipe Sells Hyderabad Land for Rs 173.96 Crore
Indian Hume Pipe Company Limited has successfully completed the sale of its freehold land in Azamabad, Hyderabad, for a total consideration of Rs 173.96 crore. The buyer, ASBL Private Limited, has paid the entire amount, and the sale deed was registered on December 30, 2025. This transaction follows the company's 2023 conversion of the land from leasehold to freehold at a cost of Rs 107.38 crore. The deal represents a significant liquidity event and value unlocking of a non-core asset.
Key Highlights
Sale of 18,311.57 Sq. Yards of land in Hyderabad for a total of Rs 173.96 crore
Entire sale consideration already received from buyer ASBL Private Limited
Land was converted to freehold in 2023 for a total cost of Rs 107.38 crore
Transaction completed and registered on December 30, 2025
The sale does not involve any related party transactions or promoter groups
👀 What to Watch
Investors should view this as a positive development that significantly boosts the company's cash reserves. Monitor the upcoming quarterly results to see how this gain is accounted for and if the funds are used to reduce debt or fund new projects.
Can Fin Homes Credits Interim Dividend of Rs 7.00 Per Share for FY 2025-26
Can Fin Homes Limited has confirmed the successful credit of its interim dividend for the financial year 2025-26. Shareholders have been paid Rs. 7.00 per equity share, which translates to a 350% payout on the face value of Rs. 2. The funds were credited on December 29, 2025, to all eligible shareholders with registered bank account details. This follows the company's previous intimation regarding the dividend declaration on December 15, 2025.
Key Highlights
Interim dividend of Rs. 7.00 per equity share credited to shareholders on December 29, 2025
Dividend payout represents 350% of the face value of Rs. 2 per share
Payment follows the initial board announcement made on December 15, 2025
Credit applies to all shareholders with updated bank particulars in company or depository records
👀 What to Watch
Shareholders should verify their registered bank accounts for the receipt of the Rs. 7.00 per share dividend. If not received, investors should contact the company's Registrar & Transfer Agent to update their bank details.
NHPC Board to Meet on Feb 4, 2026, for Q3 Results and Interim Dividend Consideration
NHPC Limited has scheduled a Board of Directors meeting on February 4, 2026, to approve un-audited financial results for the quarter and nine months ending December 31, 2025. A key highlight for shareholders is that the board will also consider a proposal for an interim dividend for the financial year 2025-26. In compliance with SEBI insider trading regulations, the trading window for designated persons will remain closed from January 1, 2026, to February 6, 2026. This announcement signals potential cash returns to investors alongside the quarterly performance update.
Key Highlights
Board meeting scheduled for February 4, 2026, to approve Q3 and 9M FY26 results
Proposal for interim dividend for FY 2025-26 to be considered during the meeting
Trading window for insiders closed from January 1, 2026, to February 6, 2026
Results will include both standalone and consolidated financial statements
👀 What to Watch
Investors should watch for the dividend announcement on February 4th, as NHPC is known for consistent payouts. Monitor the Q3 earnings for growth in power generation revenue and operational efficiency.
NHPC Declares Commercial Operation of 250 MW Unit at Subansiri Lower Project
NHPC Limited has officially declared the Commercial Operation (CoD) of Unit #2 (250 MW) of its flagship Subansiri Lower Hydroelectric Project, effective from December 23, 2025. This project, located in Assam and Arunachal Pradesh, has a total planned capacity of 2000 MW across 8 units. The commissioning of this unit follows a successful trial run and represents a crucial step in operationalizing India's largest hydroelectric project. Revenue generation from this unit will begin immediately, while the remaining 1,750 MW capacity is expected to be commissioned in phases.
Key Highlights
Unit #2 with 250 MW capacity starts commercial operations on December 23, 2025
Subansiri Lower is a 2000 MW project consisting of 8 units of 250 MW each
Marks a major milestone for NHPC's largest under-construction hydroelectric project
Commercial Operation (CoD) was declared following the successful completion of trial runs
Remaining 7 units totaling 1750 MW to be commissioned and announced in due course
👀 What to Watch
This is a significant de-risking event for NHPC's largest project; investors should maintain a positive outlook as incremental capacity starts contributing to the bottom line. Monitor the commissioning schedule of the remaining units for full revenue potential.
Narayana Hrudayalaya Schedules NCLT-Directed Meetings on Jan 19, 2026, for MMRHL Merger
Narayana Hrudayalaya (NH) has scheduled NCLT-convened meetings on January 19, 2026, to seek approval for the amalgamation of its subsidiary, Meridian Medical Research & Hospital Ltd. (MMRHL), with itself. The meetings will involve equity shareholders, secured creditors, and unsecured creditors of both entities via video conferencing. This follows the NCLT Bengaluru Bench order dated December 2, 2025, and prior approvals from BSE and NSE in June 2025. The merger is intended to streamline the corporate structure and integrate subsidiary operations directly into the parent company.
Key Highlights
NCLT-directed meetings for shareholders and creditors are scheduled for January 19, 2026.
The merger involves the total integration of subsidiary Meridian Medical Research & Hospital Ltd. into NH.
Remote e-voting for shareholders is set to take place between January 16 and January 18, 2026.
The scheme previously received observation letters from BSE and NSE on June 23 and June 24, 2025, respectively.
The cut-off date for determining eligibility for e-voting is January 12, 2026.
👀 What to Watch
Investors should monitor the voting results of the January 19 meeting as the merger will consolidate financials and simplify the group structure. Shareholders as of the January 12 cut-off date are encouraged to participate in the e-voting process.
NH Schedules Shareholder and Creditor Meetings for MMRHL Merger on Jan 19, 2026
Narayana Hrudayalaya (NH) has announced NCLT-convened meetings for its shareholders and creditors on January 19, 2026, to seek approval for the amalgamation of its subsidiary, Meridian Medical Research & Hospital Ltd. (MMRHL), with itself. This follows the NCLT Bengaluru Bench order dated December 02, 2025, and prior observation letters from BSE and NSE received in June 2025. The merger is part of a strategic consolidation to streamline operations and corporate structure. Shareholders can exercise their voting rights through remote e-voting between January 16 and January 18, 2026.
Key Highlights
Meetings for NH equity shareholders and creditors scheduled for January 19, 2026, via video conferencing.
Amalgamation involves Meridian Medical Research & Hospital Ltd. (Transferor) merging into Narayana Hrudayalaya Ltd. (Transferee).
Remote e-voting period is set from January 16, 2026 (9:00 AM) to January 18, 2026 (5:00 PM).
Observation letters for the scheme were previously obtained from BSE (June 23, 2025) and NSE (June 24, 2025).
Specific meeting times set for Secured Creditors (2:00 PM) and Unsecured Loan Creditors (3:00 PM) on the meeting date.
👀 What to Watch
Investors should monitor the voting outcomes as this merger will simplify the group's corporate structure and potentially lead to operational synergies. No immediate action is required other than participating in the e-voting process if eligible.
Narayana Hrudayalaya to Hold Meetings on Jan 19, 2026 for Merger of Subsidiary MMRHL
Narayana Hrudayalaya (NH) has received directions from the NCLT Bengaluru Bench to convene meetings of its shareholders and creditors on January 19, 2026. The purpose is to seek approval for the amalgamation of its subsidiary, Meridian Medical Research & Hospital Ltd. (MMRHL), into NH. The merger is being conducted under Sections 230 to 232 of the Companies Act, 2013, to streamline the group's corporate structure. Remote e-voting for shareholders is scheduled to take place from January 16 to January 18, 2026.
Key Highlights
NCLT Bengaluru Bench ordered meetings for shareholders and creditors to be held on January 19, 2026, via VC/OAVM.
The scheme involves the amalgamation of subsidiary Meridian Medical Research & Hospital Ltd. into the parent company, Narayana Hrudayalaya Ltd.
Remote e-voting period is set from January 16, 2026 (9:00 AM) to January 18, 2026 (5:00 PM) with a cut-off date of January 12, 2026.
Separate meeting times have been scheduled for Equity Shareholders (12:00 PM), Secured Creditors (2:00 PM), and Unsecured Creditors (3:00 PM and 4:00 PM).
The merger process follows previous observation letters issued by BSE and NSE in June 2025.
👀 What to Watch
Investors should monitor the outcome of the January 19 meeting and may participate in the e-voting process starting January 16. Since this is a merger of a subsidiary, it is a structural consolidation that is unlikely to significantly impact consolidated financial performance.
NH to Hold Shareholder Meeting on Jan 19, 2026 for Merger with Subsidiary MMRHL
Narayana Hrudayalaya (NH) has scheduled a meeting for its equity shareholders and creditors on January 19, 2026, to approve the merger of its subsidiary, Meridian Medical Research & Hospital Ltd. (MMRHL), into the parent company. This follows an order from the NCLT Bengaluru Bench dated December 02, 2025. Remote e-voting for the resolution will be open from January 16 to January 18, 2026. The amalgamation is intended to simplify the corporate structure and integrate the subsidiary's operations directly into NH.
Key Highlights
NCLT-directed shareholder meeting scheduled for January 19, 2026, at 12:00 Noon via VC/OAVM.
Amalgamation of subsidiary Meridian Medical Research & Hospital Ltd. with Narayana Hrudayalaya Ltd.
Remote e-voting period set from January 16, 2026 (9:00 AM) to January 18, 2026 (5:00 PM).
Cut-off date for determining eligibility for e-voting is January 12, 2026.
SEBI observation letters from BSE and NSE were previously obtained in June 2025.
👀 What to Watch
Shareholders should participate in the e-voting process between January 16-18 to support the corporate restructuring. This merger is a positive step toward operational consolidation and administrative cost reduction.
NHPC Completes Successful Trial Run of 250 MW Unit #2 at Subansiri Lower Project
NHPC Limited has achieved a significant milestone with the successful trial run of Unit #2 (250 MW) at its Subansiri Lower Hydroelectric Project on December 18, 2025. This project, located on the Assam/Arunachal Pradesh border, is a massive 2,000 MW undertaking comprising eight units of 250 MW each. The completion of this trial run indicates that the project is moving steadily toward commercial operations after various historical delays. This development is expected to eventually contribute significantly to NHPC's power generation capacity and revenue stream.
Key Highlights
Successful trial run of Unit #2 with 250 MW capacity completed on December 18, 2025.
Subansiri Lower HE Project has a total installed capacity of 2,000 MW (8 x 250 MW units).
The project is a critical asset for NHPC located at the Assam and Arunachal Pradesh border.
Trial run completion marks a key step toward full commercial commissioning of the unit.
👀 What to Watch
Investors should maintain a positive outlook as NHPC nears the monetization of its largest project; monitor for the official Commercial Operation Date (COD) announcement.
Can Fin Homes Declares Interim Dividend of Rs 7 Per Share; Sets Record Date for Dec 19
Can Fin Homes has declared an interim dividend of Rs 7 per equity share for the financial year 2025-26, which is a 350% payout on the face value of Rs 2. The company has established December 19, 2025, as the record date to identify eligible shareholders for this payment. The dividend is scheduled to be credited or dispatched to shareholders on or before January 13, 2026. Investors are reminded that this dividend is taxable, and the company will deduct TDS based on the shareholder's residential status and submitted documentation.
Key Highlights
Interim dividend of Rs 7 per equity share declared for the financial year 2025-26
Record date for determining eligibility is fixed as December 19, 2025
Dividend payment to be completed on or before January 13, 2026
Deadline for submitting tax exemption documents is December 22, 2025
Mandatory electronic payment mode implemented in compliance with SEBI circulars
👀 What to Watch
Investors should ensure their bank account details are updated with their Depository Participant to receive the dividend electronically. Those eligible for tax exemptions should submit the necessary forms by December 22 to avoid standard TDS rates.
Can Fin Homes Declares ₹7 Interim Dividend and Re-appoints Suresh Iyer as MD & CEO
Can Fin Homes has declared an interim dividend of ₹7.00 per equity share (350% of face value) for FY 2025-26, with the record date set for December 19, 2025. The Board also approved the re-appointment of Suresh Srinivasan Iyer as MD & CEO for a further two-year term starting March 18, 2026. This leadership continuity is subject to RBI approval, for which an application has already been submitted. The dividend is expected to be credited to eligible shareholders by January 13, 2026.
Key Highlights
Declared an interim dividend of ₹7.00 per equity share (350% of ₹2 face value).
Fixed December 19, 2025, as the record date for determining dividend eligibility.
Re-appointed Suresh Srinivasan Iyer as MD & CEO for a 2-year term effective March 18, 2026.
The MD re-appointment is pending prior approval from the Reserve Bank of India (RBI).
Suresh Iyer brings over 25 years of specialized experience from Gruh Finance and Bandhan Bank.
👀 What to Watch
Investors should ensure they hold shares before the December 19 record date to qualify for the ₹7 dividend and can view the MD's re-appointment as a positive sign of leadership stability.
Can Fin Homes declares Interim Dividend of ₹7 per share
Can Fin Homes Limited declared an interim dividend of ₹7.00 per equity share (350% of face value ₹2) for the financial year 2025-26. The record date to determine eligible shareholders for the dividend is December 19, 2025. The interim dividend will be credited to shareholders on or before January 13, 2026, which is within 30 days from the declaration date. The board also approved the re-appointment of Shri Suresh Srinivasan Iyer as Managing Director & CEO for a further period of 2 years w.e.f. March 18, 2026, subject to RBI approval.
Key Highlights
Interim Dividend of ₹7.00 per equity share
350% dividend on face value of ₹2 per share
Record Date: December 19, 2025
Dividend to be credited on or before January 13, 2026
Re-appointment of Shri Suresh Srinivasan Iyer for 2 years w.e.f. March 18, 2026
👀 What to Watch
Shareholders should note the record date for dividend eligibility. Monitor for RBI approval regarding the re-appointment of the Managing Director & CEO.
Narayana Hrudayalaya (NH): Demerger of Clinical Services Approved
Narayana Hrudayalaya Ltd. (NH) has announced the approval of a scheme of arrangement involving the demerger of the Clinical Services undertaking from NH Integrated Care Private Limited (NHIC) into Narayana Hrudayalaya Limited (NHL). The turnover of the Clinical Services undertaking for the year ended March 31, 2025, was ₹39.94 crore, representing 1.11% of NHL's total standalone turnover. This demerger aims to allow NHIC to focus on preventive healthcare and transfer clinical services to NHL for unified patient care pathways. NHL shall continue to hold 100% of equity share capital of NHIC.
Key Highlights
Demerger of Clinical Services undertaking of NH Integrated Care Private Limited (NHIC) into Narayana Hrudayalaya Limited (NHL).
Turnover of the Clinical Services undertaking for the year ended March 31, 2025 was ₹39.94 crore.
Clinical Services turnover represents 1.11% of the total standalone turnover of the Resulting Company for the year ended March 31, 2025.
NHL will continue to hold 100% of equity share capital of NHIC.
👀 What to Watch
Investors should monitor the progress of the scheme, including regulatory approvals and NCLT approval. The impact on Narayana Hrudayalaya's financials will likely be minor given the small size of the demerged entity.
Narayana Hrudayalaya Board Approves NHIC Demerger Scheme
Narayana Hrudayalaya Ltd. (NHL) has approved a scheme of arrangement to demerge the Clinical Services undertaking from its wholly-owned subsidiary, NH Integrated Care Private Limited (NHIC). The turnover of the demerged Clinical Services undertaking was ₹39.94 crore for the year ended March 31, 2025, representing 1.11% of NHL's total standalone turnover. NHL will consolidate administrative functions and optimize resource deployment. There will be no change in the shareholding pattern of NHL as a result of this demerger.
Key Highlights
Demerger of Clinical Services undertaking from NH Integrated Care Private Limited (NHIC) to Narayana Hrudayalaya Limited (NHL).
Turnover of the Clinical Services undertaking was ₹39.94 crore for the year ended March 31, 2025.
Clinical Services turnover represents 1.11% of the total standalone turnover of NHL for the year ended March 31, 2025.
Appointed Date for the Scheme is April 1, 2025.
👀 What to Watch
Investors should monitor the progress of the scheme, including receipt of regulatory approvals and NCLT approval. The demerger is expected to improve operational efficiency and unlock value.
